Citation Impact
Citing Papers
The Effects of AZT and DDI on Pre- and Postimplantation Mammalian Embryos: An In Vivo and In Vitro Study
1992
The Organization, Promoter Analysis, and Expression of the Human PPARγ Gene
1997 Standout
Genetic Analysis of Childhood Endodermal Sinus Tumors by Comparative Genomic Hybridization
2000
Hepatocellular carcinoma
2003 Standout
Comparative studies on nafenopin-induced hepatic peroxisome proliferation in the rat, Syrian hamster, guinea pig, and marmoset
1989
Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist
1999 Standout
Gene mutation of transforming growth factor ?1 type II receptor in hepatocellular carcinoma
1999
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
A realistic clinical perspective of tamoxifen and endometrial carcinogenesis
1996
Human Cytochrome P450 Family 4 Enzymes: Function, Genetic Variation and Regulation
2007
c-Myc-regulated microRNAs modulate E2F1 expression
2005 StandoutNature
TGF-β signaling in tumor suppression and cancer progression
2001 Standout
Mannose 6-Phosphate Receptor Targeting and its Applications in Human Diseases
2007
TGF-β signalling from cell membrane to nucleus through SMAD proteins
1997 StandoutNature
Parallel epigenetic and genetic changes in the pathogenesis of hepatitis virus-associated hepatocellular carcinoma
2005
Genomic Imprinting: Implications for Human Disease
1999
Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors
1992 StandoutNature
The potential role of lysosomes in tissue distribution of weak bases
1988
PPAR: a mediator of peroxisome proliferator action
1995
Genetics of hepatocellular carcinoma
2000
Long-term tamoxifen citrate use and potential ocular toxicity
1998
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
1990 StandoutNature
Loss of heterozygosity at chromosome 13q in hepatocellular carcinoma: identification of three independent regions
1999
Insulin and insulin-like growth factor signalling in neoplasia
2008 Standout
Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women
1997 Standout
Novel Recurrent Genetic Imbalances in Human Hepatocellular Carcinoma Cell Lines Identified by Comparative Genomic Hybridization
1999
Does tamoxifen cause cancer in humans?
1998
Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory
2005 Standout
The Plasticizer Diethylhexyl Phthalate Induces Malformations by Decreasing Fetal Testosterone Synthesis during Sexual Differentiation in the Male Rat
2000
Dose-Dependent Alterations in Androgen-Regulated Male Reproductive Development in Rats Exposed to Di(n-butyl) Phthalate during Late Gestation
2000 Standout
Testicular germ-cell tumours in a broader perspective
2005 Standout
Reproductive and developmental effects of phthalate diesters in females
2013
The Mechanism of Microsomal Azoreduction: Predictions Based on Electronic Aspects of Structure-Activity Relationships
1995
Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
1998 Standout
Toremifene: An evaluation of its safety profile
2005
P-type lectins
2002
Biochemical Mechanisms of Induction of Hepatic Peroxisome Proliferation
1989
Oncomirs — microRNAs with a role in cancer
2006 Standout
Mechanisms of mitophagy
2010 Standout
Mono-(2-ethylhexyl) phthalate stimulates basal steroidogenesis by a cAMP-independent mechanism in mouse gonadal cells of both sexes
2008
Expression of activation-induced cytidine deaminase in human hepatocytes via NF-κB signaling
2007 StandoutNobel
Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein
1999
PPARγ signaling and metabolism: the good, the bad and the future
2013 Standout
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Reproductive Effects of Di(2-ethylhexyl)phthalate in Immature Male Rats and Its Relation to Cholesterol, Testosterone, and Thyroxin Levels
2009
Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline
2003 Standout
Selective estrogen receptor modulators (SERMs): Mechanisms of anticarcinogenesis and drug resistance
2005
Clinicopathologic Studies in Cognitively Healthy Aging and Alzheimer Disease
1998
Enzyme induction in the cytochrome P-450 system
1990 Standout
Toxicokinetics of di(2-ethylhexyl) phthalate (DEHP) and its effects on luteal function in sheep
2013
M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity
1995
Utility of the Apolipoprotein E Genotype in the Diagnosis of Alzheimer's Disease
1998
Chromosomal Localisation, Inducibility, Tissue‐Specific Expression and Strain Differences in Three Murine Peroxisome‐Proliferator‐Activated‐Receptor Genes
1995
A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
2010 StandoutNature
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
Health risks posed by use of Di-2-ethylhexyl phthalate (DEHP) in PVC medical devices: A critical review
2001
Chemoprevention of Mammary Carcinogenesis in the Rat: Combined Use of Raloxifene and 9-cis-Retinoic Acid
1996
Azobenzene photoswitches for biomolecules
2011 Standout
DNA Damage Induced by Red Food Dyes Orally Administered to Pregnant and Male Mice
2001
Changes in hepatic lipid metabolism associated with lipid accumulation and its reversal in rats given the peroxisome proliferator LY171883
1990
Lysosome-targeting chimaeras for degradation of extracellular proteins
2020 StandoutNatureNobel
Peroxisome proliferator-activated receptors: finding the orphan a home
1994
Sub-chronic dietary toxicity of potassium perfluorooctanesulfonate in rats
2003
Environmental epigenomics and disease susceptibility
2007 Standout
Subchronic oral toxicity of di-n-octyl phthalate and di(2-ethylhexyl) phthalate in the rat
1997
Metabolism of AZO Dyes: Implication for Detoxication and Activation
1991
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
1994 Standout
Tumor suppressor activity of the TGF-β pathway in human cancers
1996
Isolation, complementary DNA sequence, and regulation of rat hepatic lauric acid omega-hydroxylase (cytochrome P-450LA omega). Identification of a new cytochrome P-450 gene family.
1987
Drug−Protein Adducts: An Industry Perspective on Minimizing the Potential for Drug Bioactivation in Drug Discovery and Development
2003
Estrogen Receptors as Therapeutic Targets in Breast Cancer
2008
Roles of N-Linked Glycans in the Endoplasmic Reticulum
2004 Standout
Peroxisome proliferation due to di(2-ethylhexyl) phthalate (DEHP): species differences and possible mechanisms.
1986
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
TGF-β SIGNAL TRANSDUCTION
1998 Standout
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
Protein-DNA Interactions at a Drug-responsive Element of the Human Apolipoprotein A-I Gene
1996
Chem-Bioinformatics and QSAR: A Review of QSAR Lacking Positive Hydrophobic Terms
2001 Standout
C−H Activation for the Construction of C−B Bonds
2009 Standout
Identification and characterization of DNA elements implicated in the regulation of CYP4A1 transcription
1995
Basic Guide to the Mechanisms of Antiestrogen Action
1998
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
1999 Standout
Parkin , a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25–q27
2003
The Many Roles for Fluorine in Medicinal Chemistry
2008 Standout
Comparative QSAR in Toxicology: Examples from Teratology and Cancer Chemotherapy of Aniline Mustards
1995
Polyfluorinated Compounds: Past, Present, and Future
2011 Standout
Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
1997 Standout
Identification of the proximate peroxisome proliferator(s) derived from Di(2-ethylhexyl) phthalate
1985
Reproductive toxicity of phthalate esters
2009
Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator nafenopin.
1994
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
2011 Standout
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
Liver Regeneration
1997 StandoutScience
Decontamination of wastewaters containing synthetic organic dyes by electrochemical methods. An updated review
2014 Standout
Subcellular Partitioning and Intramacrophage Selectivity of Antimicrobial Compounds against Mycobacterium tuberculosis
2017 StandoutNobel
Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ
1997 Standout
The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene.
1992
Plastic and Human Health: A Micro Issue?
2017 Standout
Do Peroxisome Proliferating Compounds Pose a Hepatocarcinogenic Hazard to Humans?
1998
Human S mu binding protein-2 binds to the drug response element and transactivates the human apoA-I promoter: role of gemfibrozil
1998 StandoutNobel
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*
1999 Standout
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
2004 Standout
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis
1997
Works of T.C. Orton being referenced
Practolol metabolism. III. Irreversible binding of [14C]practolol metabolite(s) to mammalian liver microsomes.
1981
ACCUMULATION OF AMINES IN THE ISOLATED PERFUSED RABBIT LUNG
1974
The effect of hypolipidemic agents on the hepatic microsomal drug-metabolizing enzyme system of the rat. Induction of cytochrome(s) P-450 with specificity toward terminal hydroxylation of lauric acid.
1982
XENOBIOTIC ACCUMULATION AND METABOLISM BY ISOLATED PERFUSED RABBIT LUNGS
1973
Proto-oncogene activation in liver tumors of hepatocarcinogenesis-resistant strains of mice
1992
Comparison of the acute and chronic mitogenic effects of the peroxisome proliferators methylclofenapate and clofibric acid in rat liver
1993
Teratogenicity of phenylhydantoins in an in vitro system: Molecular orbital-generated quantitative structure-toxicity relationships
1989
Comparative pharmacokinetics and subacute toxicity of di(2-ethylhexyl) phthalate (DEHP) in rats and marmosets: extrapolation of effects in rodents to man.
1986
Differentation of rat embryo cells in culture: Response following acute maternal exposure to teratogens and non‐teratogens
1984
An in vitro assay for teratogens with cultures of rat embryo midbrain and limb bud cells
1984
Two-year carcinogenicity study of tamoxifen in Alderley Park Wistar-derived rats.
1993
Comparative toxicity of di-(2-ethylhexyl)phthalate (dehp) in rats and marmosets
1983
Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors.
1995
The effects of phenobarbitone on urinary 6β-hydroxycortisol excretion and hepatic enzyme activity in the marmoset monkey (callithrix jacchus)
1980